4.5 Review

A Conceptual Framework for Understanding Multiple Tobacco Product Use and the Impact of Regulatory Action

Journal

NICOTINE & TOBACCO RESEARCH
Volume 21, Issue 3, Pages 268-277

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ntr/nty129

Keywords

-

Funding

  1. National Institutes of Health [K01 DA043413, U54 DA031659]

Ask authors/readers for more resources

Introduction Over 35% of the adult tobacco-using population regularly use more than one tobacco product. Although rates of tobacco use in the United States have declined over the last decade, rates of multiple tobacco product (MTP) have either remained stable (among adults) or increased (among youth). Methods In this paper, we review the literature and propose a framework for understanding both MTP use and how regulatory actions on any single tobacco product (STP) may influence the use of other tobacco products. Results and Conclusions Within the framework, Product, Person, and Context/Situational factors (and their interactions) influence product cross-substitution and thus patterns of use of MTPs. In addition, we propose that Context/Situation effects specifically increase the complexity of MTP-use patterns resulting in dynamic complementarity in addition to substitution-like relationships between tobacco products. Experimentation with, and use of, various tobacco products results in reinforcement histories that affect which products are used, in what contexts, and by whom, which in turn has downstream impacts on toxicant exposure and health. We conclude our analysis with an examination of how regulation of STPs can have impacts on the use of other STP and MTP use and provide research questions for further examining MTP use. Implications Though rates of tobacco use have declined in the United States, over 35% of the adult tobacco-using population regularly uses more than one tobacco product. This paper provides a framework for understanding MTP use and how regulatory actions on any STP may influence the use of other tobacco products. We conclude our analysis by providing research questions for further examining MTP use.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Toxicology

Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures

Richard C. Kevin, Alexander L. Kovach, Timothy W. Lefever, Thomas F. Gamage, Jenny L. Wiley, Iain S. McGregor, Brian F. Thomas

FORENSIC TOXICOLOGY (2019)

Article Biochemistry & Molecular Biology

Diarylureas Containing 5-Membered Heterocycles as CB1 Receptor Allosteric Modulators: Design, Synthesis, and Pharmacological Evaluation

Thuy Nguyen, Thomas F. Gamage, Ann M. Decker, Nadezhda German, Tiffany L. Langston, Charlotte E. Farquhar, Terry P. Kenakin, Jenny L. Wiley, Brian F. Thomas, Yanan Zhang

ACS CHEMICAL NEUROSCIENCE (2019)

Article Pharmacology & Pharmacy

Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain

Stevie C. Britch, Alan G. Goodman, Jenny L. Wiley, Abby M. Pondelick, Rebecca M. Craft

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)

Article Behavioral Sciences

In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018

Thomas F. Gamage, Daniel G. Barrus, Richard C. Kevin, David B. Finlay, Timothy W. Lefever, Purvi R. Patel, Megan A. Grabenauer, Michelle Glass, Iain S. McGregor, Jenny L. Wiley, Brian F. Thomas

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)

Article Clinical Neurology

Sex, species and age: Effects of rodent demographics on the pharmacology of Δ9-tetrahydrocanabinol

Jenny L. Wiley, Daniel G. Barrus, Charlotte E. Farquhar, Timothy W. Lefever, Thomas F. Gamage

Summary: The study investigated the effects of age, sex, and rodent species on the psychoactive impact of intraperitoneal THC and its metabolite 11-OH-THC. The results show that 11-OH-THC exhibited higher potency in some aspects compared to THC, suggesting that species is a crucial design consideration in preclinical studies of phytocannabinoids.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)

Article Substance Abuse

Δ9-Tetrahydrocannabinol discrimination: Effects of route of administration in rats

L. Jenny Wiley, I. Shanequa Taylor, A. Julie Marusich

Summary: The study examined the effects of THC administered through different routes on rats. Results showed varying effects of THC across different routes of administration, providing empirical evidence for choosing the route of administration for mechanistic investigation of THC's pharmacology. Animal models using translationally relevant routes of administration may lead to more accurate predictions of THC effects in humans.

DRUG AND ALCOHOL DEPENDENCE (2021)

Article Chemistry, Analytical

Thermal Degradants Identified from the Vaping of Vitamin E Acetate

Alexander L. Kovach, Randi R. Carter, Jonathan W. Thornburg, Robert Wiethe, Timothy R. Fennell, Jenny L. Wiley

Summary: Studies have found that vitamin E acetate undergoes thermal degradation in electronic vaping devices and is considered a major contributor to e-cigarette or vaping product use-associated lung injuries. By analyzing the degradation products of vitamin E acetate, researchers have identified two major compounds and suggested their potential as biomarkers for exposure and toxicity assessment.

JOURNAL OF ANALYTICAL TOXICOLOGY (2022)

Article Pharmacology & Pharmacy

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018

David B. Finlay, Thuy Nguyen, Thomas F. Gamage, Shuli Chen, Daniel G. Barrus, Purvi R. Patel, Brian F. Thomas, Jenny L. Wiley, Yanan Zhang, Michelle Glass

Summary: This study compared the synthetic cannabinoid receptor agonist EG-018 and its analogues with existing putative neutral antagonists of CB1 receptor. The results showed highly variable signaling outcomes for EG-018 analogues, with some compounds demonstrating potential as neutral antagonists. These findings provide important insights for the development of CB1 neutral antagonists.

PHARMACOLOGY RESEARCH & PERSPECTIVES (2022)

Article Substance Abuse

Assessment of dependence potential and abuse liability of ?8-tetrahydrocannabinol in mice

S. O. Vanegas, A. M. Reck, C. E. Rodriguez, J. A. Marusich, O. Yassin, G. Sotzing, J. L. Wiley, S. G. Kinsey

Summary: This study evaluates the effects of acute and repeated exposure to delta(8)-THC and finds that it produces similar effects to delta(9)-THC, including risk of drug dependence and abuse liability.

DRUG AND ALCOHOL DEPENDENCE (2022)

Article Behavioral Sciences

In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists

Julie A. Marusich, Thomas F. Gamage, Yanan Zhang, Luli R. Akinfiresoye, Jenny L. Wiley

Summary: Synthetic cannabinoid receptor agonists (SCRAs) are a novel class of psychoactive substances that bind to and activate CB1 receptors in the brain.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2022)

Article Behavioral Sciences

The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism

David B. Finlay, Warwick Mackie, Hunter D. J. Webb, Lucy R. Thomsen, Mhairi Nimick, Rhonda J. Rosengren, Julie A. Marusich, Michelle Glass, Jenny L. Wiley

Summary: AMB-FUBINACA is a synthetic cannabinoid receptor agonist associated with abuse and health harm. The study aimed to investigate the interactions between AMB-FUBINACA and pFPP in rats and mice. The results suggest that pFPP may attenuate some physiological effects of AMB-FUBINACA in rats, but there is little evidence of direct receptor interactions. Overall, combining pFPP and AMB-FUBINACA is unlikely to result in increased harm/toxicity.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2023)

Article Cardiac & Cardiovascular Systems

Δ9-Tetrahydrocannabinol Effects on Respiration and Heart Rate Across Route of Administration in Female and Male Mice

Lucas T. Laudermilk, Julie A. Marusich, Jenny L. Wiley

Summary: This study investigates the effects of sex and route of administration on THC-induced changes in cardiopulmonary phenotypes in mice. The results demonstrate that THC alters respiratory minute volume and heart rate across different administration routes, with varying effects in duration and direction.

CARDIOVASCULAR TOXICOLOGY (2023)

Article Behavioral Sciences

Experimenter administered Δ9-THC decreases nicotine self-administration in a rat model

Antony D. Abraham, Jenny L. Wiley, Julie A. Marusich

Summary: This study found that THC has an impact on nicotine intake in rat models, decreasing self-administration of nicotine and altering the dose-effect curve. Unlike nicotine, THC does not affect the response to sucrose.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2023)

Article Substance Abuse

Δ9-tetrahydrocannabinol discrimination: Effects of route of administration in mice

Julie A. Marusich, Jenny L. Wiley

Summary: This study examined the effect of different routes of administration on the potency and time course of THC's discriminative stimulus properties. The results showed that THC administered through various routes produced similar stimulus effects. These findings have implications for predicting THC's effects in humans.

DRUG AND ALCOHOL DEPENDENCE REPORTS (2023)

No Data Available